Expert Adviser:

Brooke’s background, including a Ph.D. and Postdoc in molecular biology and years of consulting experience, is reflected in her impactful analyses of the Glioblastoma (GBM) landscape. Through the ONCrg Advisory services, you can contact Brooke directly for personalized answers to non-proprietary questions, targeted analyses, and custom insights in GBM.   More

GBM Oncology Resources

Medical Conference Coverage:

ONCrg Conference covers the entire GBM landscape and delivers expert analysis of noteworthy scientific, clinical, and commercial changes at major medical conferences. Scientific conferences provide updates on evolving mechanisms and strategies for development in both newly diagnosed and recurrent GBM.   More

Competitive Landscape Analysis:

GBM has proven difficult to treat, with few approved therapies and a high failure rate, even for late-stage pipeline products. This provides an opportunity for rapid advancement if promising efficacy can be shown. Quarterly reports deliver cutting edge profiles across the entire competitive landscape, providing valuable analytics for new drugs in Phase I/II development and beyond.   More

Monthly Surveillance Reports:

ONCrg Sentinel provides vigilant monitoring of rapidly evolving scientific, clinical, and commercial activities in oncology. ONCrg experts deliver incisive commentaries on current news events to inform subscribers each month, preparing them to respond wisely to ever-changing market conditions.   More